I-CANVAX 2024: Innovative Cancer Vaccine Development
Global and Indian Synergies
December 12, 2024
Kolkata, India
The inaugural conference organized by TCG CREST CARE aims to bring together leading experts, researchers, and stakeholders in the field of cancer vaccine development to foster collaboration, share groundbreaking research, and discuss innovative strategies for combating cancer. This conference seeks to highlight the importance of cancer vaccine development both globally and within the Indian context, showcasing advancements and fostering partnerships that can drive future research and development.
Venue
TCG Centres for Research and Education in Science and Technology, TCG CREST
1st Floor, Bengal Eco Intelligent Park, Block EM, Sector V, Salt Lake, Kolkata 700091,
West Bengal, INDIA
Pleae click here for Google Map Location
Why TCG CREST CARE is Organizing This Conference
TCG CREST CARE, a premier research institute focused on cancer research and education, is dedicated to advancing the understanding and treatment of cancer through cutting-edge research and collaboration. By organizing this conference, TCG CREST CARE aims to:
- Establish itself as a leader in the field of cancer research and vaccine development.
- Create a platform for knowledge exchange and networking among global and Indian experts.
- Promote collaborative efforts to enhance cancer prevention and treatment strategies.
- Highlight the institute’s commitment to addressing the cancer burden in India and beyond.
Global Importance
Cancer remains a leading cause of death worldwide, with millions of new cases diagnosed each year. The development of effective cancer vaccines represents a significant advancement in the fight against cancer, offering the potential to prevent and treat various types of cancer more effectively. This conference will showcase:
- Innovative research and clinical trials from leading global institutions.
- Breakthroughs in cancer vaccine technology, including mRNA and personalized vaccines.
- Collaborative efforts to accelerate the development and implementation of cancer vaccines.
Indian Context
India faces a substantial cancer burden, with increasing incidence rates and significant challenges in cancer prevention and treatment. This conference will address:
- The unique challenges and opportunities in developing cancer vaccines in India.
- The role of Indian research institutions and collaborations in advancing cancer vaccine development.
- Success stories of indigenous vaccine development and their impact on public health.
- Strategies to enhance India’s capacity to develop and distribute effective cancer vaccines.
Key Themes
- International Cancer Vaccine Efforts: Insights from leading global experts and institutions on innovative cancer vaccine research and clinical trials.
- Lung Cancer Vaccine Initiatives: Focus on lung cancer vaccine research, including collaborations with Indian institutions and international partners.
- Indigenous Vaccine Development: Highlighting India’s achievements in developing homegrown cancer vaccines and the impact on public health.
Organizing Committee
Dr. Purnendu Chatterjee, Chairman, TCG CREST
Swapan Bhattacharya, Director, TCG CREST
Mansoor M. Ahmed, Ph.D. (CARE/EINSTEIN, USA)
Vivek Mittal, Ph.D. (CARE/CORNELL, USA)
Chandan Guha, MBBS., Ph.D. (CARE/EINSTEIN, USA)
Ashish Goyal, Ph.D. (DKFZ, Germany)
Sonali Das, Ph.D. (CARE/TCGLS, India)
Please click here for I-CANVAX 2024 Poster